Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Astrazeneca shares fall on flat Crestor results. Pfizer To Benefit From FDA Approval of Lung Cancer Drug.
Astrazeneca shares fall on flat Crestor results. Pfizer To Benefit From FDA Approval of Lung Cancer Drug.
Astrazeneca shares fall on flat Crestor results. Pfizer To Benefit From FDA Approval of Lung Cancer Drug.
Submitted by
moderatorj
on September 2, 2011 - 9:16pm
Source:
BioMed Reports
News Tags:
Astrazena
Pfizer
FDA
Headline:
Astrazeneca shares fall on flat Crestor results. Pfizer To Benefit From FDA Approval of Lung Cancer Drug.
Do Not Allow Advertisers to Use My Personal information
